Kanji Hojo
- Molecular Biology
- Cancer Research top 10%
- Oncology top 10%
- Hematology top 10%
- Biotechnology top 5%
- Co-authors
- Hideo MakiHikaru SonodaHideki OhtaYasufumi SatoHiroshi YamashitaYasuhiro HasegawaMayumi AbéKazue Shimizu
- Topics
- Protease and Inhibitor Mechanisms (4 papers)Lung Cancer Treatments and Mutations (4 papers)Cancer Research and Treatments (2 papers)
- Journals
- Nucleic Acids ResearchJournal of Clinical InvestigationBiochemical and Biophysical Research Communications
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Kanji Hojo
21 papers receiving 959 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 560
- Cancer Research 261
- Oncology 242
- Hematology 141
- Biotechnology 128
Countries citing papers authored by Kanji Hojo
This map shows the geographic impact of Kanji Hojo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanji Hojo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanji Hojo more than expected).
Fields of papers citing papers by Kanji Hojo
This network shows the impact of papers produced by Kanji Hojo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanji Hojo. The network helps show where Kanji Hojo may publish in the future.
Co-authorship network of co-authors of Kanji Hojo
This figure shows the co-authorship network connecting the top 25 collaborators of Kanji Hojo. A scholar is included among the top collaborators of Kanji Hojo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanji Hojo. Kanji Hojo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 78 | |
| 3 | 6 | |
| 4 | 6 | |
| 5 | 240 | |
| 6 | 245 | |
| 7 | Augmented growth inhibition of B16-BL6 melanoma by combined treatment with a selective matrix metalloproteinase inhibitor, MMI-166, and cytotoxic agents. | 5 |
| 8 | 9 | |
| 9 | 1 | |
| 10 | 16 | |
| 11 | 11 | |
| 12 | Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor. | 53 |
| 13 | [Augmented antitumor efficacy of combination chemotherapy of nedaplatin with 5-fluorouracil in in vivo murine and human tumor model]. | 1 |
| 14 | 29 | |
| 15 | Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase. | 132 |
| 16 | 84 | |
| 17 | 12 | |
| 18 | 5 | |
| 19 | 9 | |
| 20 | 10 |
About Kanji Hojo
Kanji Hojo is a scholar working on Oncology, Cancer Research and Biotechnology, having authored 21 papers that have together received 974 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Cancer Research (261 citations), Immunology and Allergy (105 citations) and Biotechnology (128 citations). Kanji Hojo has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Hideo Maki, Hikaru Sonoda, Hideki Ohta, Yasufumi Sato, Hiroshi Yamashita, Yasuhiro Hasegawa, Mayumi Abé, Kazue Shimizu, Kazuhide Watanabe and Yuanying Ding. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Investigation and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.